Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
28
FNA Quote, Financials, Valuation and Earnings
Last price:
$13.03
Seasonality move
:
-9.5%
Day range:
$13.00 - $13.03
52-week range:
$4.65 - $13.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.23x
P/B ratio:
8.36x
Volume:
1.2M
Avg. volume:
1.9M
1-year change:
42.65%
Market cap:
$1.1B
Revenue:
$256.2M
EPS (TTM):
-$0.67
Paragon 28 Number of Institutional Trades
Paragon 28 Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$366.4M
(Last 6 Months)
Current Institutional Ownership Percentage
70.22%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$908.4M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Paragon 28 Institutional Ownership
-
What Percentage Of FNA Is Owned by Institutions?
70.22% of FNA is owned by institutions.
-
How Many Institutions Own FNA Shares?
Paragon 28 stock is owned by 289 institutional shareholders at this time.
-
Have Institutions Been Buying FNA Stock?
Yes, institutions have bought 15.9M shares of FNA in the last quarter.
-
Have Institutions Been Selling FNA Stock?
Yes, institutions have sold 57.1M shares of FNA over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
